Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia

被引：15

作者：

De Melo, Valeria A. S. ^{[1
]}

Milojkovic, Dragana ^{[1
]}

Khorashad, Jamshid S. ^{[1
]}

Marin, David ^{[1
]}

Goldman, John M. ^{[1
]}

Apperley, Jane F. ^{[1
]}

Reid, Alistair G. ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London W12 0NN, England

来源：

BLOOD | 2007年 / 110卷 / 08期

关键词：

D O I：

10.1182/blood-2007-05-092437

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3086 / 3087

页数：2

共 7 条

[1] Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].

Bumm, T ;

Müller, C ;

Al-Ali, HK ;

Krohn, K ;

Shepherd, P ;

Schmidt, E ;

Leiblein, S ;

Franke, C ;

Hennig, E ;

Friedrich, T ;

Krahl, R ;

Niederwieser, D ;

Deininger, MWN .

BLOOD, 2003, 101 (05) :1941-1949

[2] Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases [J].

Fayad, L ;

Kantarjian, H ;

OBrien, S ;

Seong, D ;

Albitar, M ;

Keating, M ;

Talpaz, M .

LEUKEMIA, 1997, 11 (05) :767-771

[3]

HAGEMEIJER A, 1979, BLOOD, V53, P1

[4] t(3;21) following peripheral blood stem cell transplantation in chronic phase chronic myeloid leukaemia [J].

Jacob, A ;

Griffiths, M ;

Larkins, S ;

Holmes, J .

BONE MARROW TRANSPLANTATION, 1997, 19 (12) :1255-1258

[5] The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase [J].

Sneed, TB ;

Kantarjian, HM ;

Talpaz, M ;

O'Brien, S ;

Rios, MB ;

Bekele, BN ;

Zhou, M ;

Resta, D ;

Wierda, W ;

Faderl, S ;

Giles, F ;

Cortes, JE .

CANCER, 2004, 100 (01) :116-121

[6] Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia [J].

Terre, C ;

Eclache, V ;

Rousselot, P ;

Imbert, M ;

Charrin, C ;

Gervais, C ;

Mozziconacci, MJ ;

Maarek, O ;

Mossafa, H ;

Auger, N ;

Dastugue, N ;

Talmant, P ;

Van den Akker, J ;

Leonard, C ;

Khac, FN ;

Mugneret, F ;

Viguié, F ;

Lafage-Pochitaloff, M ;

Bastie, JN ;

Roux, GL ;

Nicolini, F ;

Maloisel, F ;

Vey, N ;

Laurent, G ;

Recher, C ;

Vigier, M ;

Yacouben, Y ;

Giraudier, S ;

Vernant, JP ;

Salles, B ;

Roussi, J ;

Castaigne, S ;

Leymarie, V ;

Flandrin, G ;

Lessard, M .

LEUKEMIA, 2004, 18 (08) :1340-1346

[7] Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia [J].

Zaccaria, Alfonso ;

Valenti, Anna Maria ;

Donti, Emilio ;

Gozzetti, Alessandro ;

Ronconi, Sonia ;

Spedicato, Francesco .

HAEMATOLOGICA, 2007, 92 (04) :564-565

← 1 →